The LLSC Blood Cancer Quality of Life Grant 2027, offered by the Leukemia & Lymphoma Society of Canada, supports research addressing challenges experienced by people with blood cancers and their caregivers.
Projects may examine fear of recurrence, treatment effects, financial difficulties, return to work, daily functioning or survivorship care. Interventional and observational studies using quantitative, qualitative or mixed methods are welcome.
Eligibility Criteria
- Principal investigators must be based at, or formally affiliated with, a Canadian nonprofit sponsoring institution throughout the award.
- Applicants must hold an appointment permitting independent research, trainee supervision and publication.
- Principal investigators should hold a PhD, MD, DVM or equivalent degree.
- Researchers from any field may apply, provided the proposal directly addresses blood cancer.
- Early-career investigators are encouraged to apply.
- Applicants may participate as PI or co-PI on only one application per cycle.
- Trainees, postdoctoral fellows and investigators working outside Canada cannot serve as PI.
- The research environment must provide suitable resources and access to patient materials where applicable.
Funding Details
- Maximum award: CAD $150,000.
- Annual maximum: CAD $75,000.
- Duration: Two years.
Deadline
- Mandatory LOI: December 3, 2026, at 4:00 p.m. EST.
- Invited full application: February 10, 2027, at 4:00 p.m. EST.
- Notification: Fall 2027.
- Award start: November 1, 2027.
Further Information
- Official programme page
- Current application guidelines
- Apply through ProposalCentral
- Contact: paul.oconnell@lls.org